28.02.2013 Views

annual meeting program - American Society of Clinical Oncology

annual meeting program - American Society of Clinical Oncology

annual meeting program - American Society of Clinical Oncology

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

8:00 AM - 9:15 AM<br />

EDUCATION SESSIONS<br />

Building Bridges for Successful Breast Cancer Survivorship Care<br />

Location: E354a<br />

CME credit: 1.25<br />

Track(s): Breast Cancer; Geriatric <strong>Oncology</strong>; Patient and Survivor Care<br />

Claire Frances Snyder, PhD—Chair<br />

The Johns Hopkins University School <strong>of</strong> Medicine<br />

Coordination <strong>of</strong> Care in Breast Cancer Survivors: An Overview<br />

Sharon Hermes Giordano, MD<br />

University <strong>of</strong> Texas M. D. Anderson Cancer Center<br />

Impact <strong>of</strong> Comorbid Conditions on Breast Cancer Survivorship<br />

Larissa Nekhlyudov, MD, MPH<br />

Harvard Medical School<br />

Information and Training Needs <strong>of</strong> Primary Care Providers to Promote Quality Care for Breast<br />

Cancer Survivors<br />

Eva Grunfeld, MD, D.Phil<br />

University <strong>of</strong> Toronto<br />

Communication Strategies, Models, and Tools for Partnerships between Primary Care and<br />

<strong>Oncology</strong> Care to Provide Quality Breast Cancer Survivorship Care<br />

Comparative Effectiveness Research in <strong>Oncology</strong>: Opportunities and<br />

Challenges<br />

Location: S404<br />

CME credit: 1.25<br />

Track(s): Health Services Research; Patient and Survivor Care<br />

Neal J. Meropol, MD—Chair<br />

University Hospitals Case Medical Center<br />

Comparative Effectiveness Research to Address Uncertainties in <strong>Oncology</strong> Practice<br />

Gary H. Lyman, MD, MPH<br />

Duke Comprehensive Cancer Center<br />

Comparative Effectiveness Research: What Is It and Why Is It Important?<br />

Jerome Seidenfeld, PhD<br />

<strong>American</strong> <strong>Society</strong> <strong>of</strong> <strong>Clinical</strong> <strong>Oncology</strong><br />

Methods <strong>of</strong> Comparative Effectiveness Research in <strong>Oncology</strong><br />

Developing Drugs in Special Populations: Organ Dysfunction Studies<br />

Location: E354b<br />

CME credit: 1.25<br />

Track(s): Developmental Therapeutics; <strong>Clinical</strong> Trials; Gastrointestinal (Noncolorectal) Cancer<br />

Daniel Mulkerin, MD—Chair<br />

University <strong>of</strong> Wisconsin<br />

Renal Dysfunction Studies<br />

Ghassan K. Abou-Alfa, MD<br />

Memorial Sloan-Kettering Cancer Center<br />

Liver Dysfunction Studies<br />

Shiew-Mei Huang, PhD<br />

U.S. Food and Drug Administration<br />

Regulatory Considerations for Organ Dysfunction Studies<br />

Tuesday, June 8, 2010<br />

417<br />

TUESDAY

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!